Project Grant R44CA285121
Award Date 9/1/23
Completion Date 8/31/25
Dollars Obligated $2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- This Project Grant, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), funds the development of statistical and computational tools for analyzing complex spatial transcriptomics (ST) data. The $769,444 award to Emory University, effective September 1, 2025, through June 30, 2030, supports the creation of analytic methodologies to integrate multi-view, multi-section, and multi-sample ST datasets. Aim 1...
- This Project Grant from the National Institutes of Health's National Cancer Institute totaling $668,151 will support the development of highly multiplexed live-cell G protein-coupled receptor (GPCR) arrays for glioma drug discovery. Spectragenetics, Inc. will deploy an automated multiplexed live-cell assay to detect and quantify agonist and inverse-agonist activities against 55 GPCRs known to be upregulated or downregulated in human gliomas. The assay will be used to screen 48 established...
- Grant Award Summary The National Cancer Institute (NCI) awarded a $450,904 Project Grant to the Pacific Northwest National Laboratory (PNNL), a division of Battelle Memorial Institute, under the Cancer Biology Research program (CFDA 93.396) for the period September 1, 2025, through August 31, 2028. The funded project will develop a novel single-cell (phospho-)proteomics platform designed to characterize tumor microenvironment (TME) components—including cancer cells, immune cells, and stromal...
- This $399,499 Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), supports the development of Liquid Biotech's TELOMESCAN circulating tumor cell (CTC) assay for monitoring non-small cell lung cancer (NSCLC) patients undergoing radiation and immunotherapy. The key products and services to be delivered through this funding include: 1) Developing a clinical prototype of the TELOMESCAN assay with automated analysis to...
- Federal Grant Award Summary Xgenomes Corp. received a $399,816 Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) beginning September 1, 2025, with completion scheduled for August 31, 2026. The company is developing a novel circulating tumor DNA (ctDNA) analysis platform that directly measures both genetic mutations and DNA methylation changes with accuracy approximately 100 times greater than current next-generation...
- Pumpkinseed Technologies Inc. received a $353,204 Phase I Small Business Innovation Research (SBIR) Project Grant award from the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396) on June 19, 2025, with completion targeted for April 30, 2026. The award funds development and proof-of-concept demonstration of Cell-MAPP (Cell Monitoring Against Presented Peptides), a novel technology that enables dynamic, real-time monitoring of individual T cell states during antigen...
- New York University School of Medicine received a $703,227 Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research program (CFDA 93.394) awarded June 1, 2026, with a completion date of May 31, 2031. The grant supports development of an ultra-rapid droplet digital polymerase chain reaction (ddPCR) technology platform designed to deliver molecular-genetic profiling of cancer-driving mutations directly within the operating room during surgical resection...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Translational Genomics Research Institute (TGen) a $305,960 Project Grant (CFDA 93.853: Extramural Research Programs in the Neurosciences and Neurological Disorders) effective April 15, 2026, through March 31, 2028. Under this award, TGen will deliver spatial transcriptomics analysis and computational modeling services to map the molecular characteristics and dissemination patterns of glioma...
- FIND-SEQ Cell Sorting Technology Development and Commercialization The National Institute on Aging awarded Vivid Bioinnovations, PBC (operating as Fluid Discovery, Inc.) a $613,742 Project Grant under the Aging Research program (CFDA 93.866) on September 12, 2025, with a completion date of February 28, 2027. This Fast-Track Small Business Innovation Research (SBIR) award supports the translation and commercial development of FIND-SEQ, a novel cell sorting technology that enables isolation of...
- This $255,991 National Science Foundation project grant supports the development of an automated system for rapid analysis of biopsy samples by Amcyt, Inc. The system aims to increase the efficiency and accessibility of fine needle aspiration biopsy procedures through three automated processes: sample smearing, staining, and image capture. This addresses a critical need to improve biopsy analytics and potentially eliminate up to 20% of failed procedures due to sampling errors. By automating...